-
摘要: 目的:了解变应性鼻炎单螨抗原免疫治疗期间主诉症状视觉模拟评分(VAS)波动情况及原因。方法:我们对376例变应性鼻炎患者进行单螨抗原免疫治疗,并对患者症状情况进行主诉症状VAS评分,制成图表;同时对可能影响症状的相关因素进行随访。结果:变应性鼻炎单螨抗原免疫治疗后,在第8、18、22、25、29、34次注射抗原时,主诉症状VAS评分呈波动性升高,其后逐渐下降,至整个治疗过程结束时达最低点水平。综合分析发现患者的期望值、情绪、社会经济状况、生活环境、再次接触变应原以及儿童不能准确的表达等都是导致评分波动的因素。结论:患者的期望值、情绪、社会经济状况、生活环境、再次接触变应原以及儿童不能准确的表达等都可以导致症状VAS评分波动,提示变应性鼻炎单螨抗原免疫治疗前需进行健康教育。Abstract: Objective: To understand the fluctuation of symptomatic visual analogue scale(VAS)score and its reasons during the allergic rhinitis patients treated with single-mite antigen immunotherapy.Method: Three hundred and seventy six patients with allergic rhinitis were treated with single-mite antigen immunotherapy and their symptoms were evaluated by VAS score and chart, the relative factors which could affect the symptom were followed up.Result: During the allergic rhinitis patients treated with single-mite antigen immunotherapy, the symptomatic VAS score appeared fluctuation from the 8th to 34th time of therapy. The VAS score increased at the 8 th, 18 th, 22 th, 25 th, 29 th, and 34 th time. Afterwards, it generally decreased to a lowest level of the whole treatment process in the last. The comprehensive analysis implied that the factors resulting in VAS score fluctuation were patients' expectation, emotion, socio-economic conditions, living environment, re-contact of allergen and children's unclear complain.Conclusion: Patients' expectation, emotion, socio-economic conditions, living environment, re-contact of allergen and children's unclear complain can result in symptomatic VAS score fluctuation. It prompts that health education be necessary before the treatment of allergic rhinitis with single-mite antigen immunotherapy.
-
Key words:
- rhinitis,allergic /
- mites /
- immunotherapy /
- visual analogue scale
-
-
[1] 韩德民,张罗,黄丹,等.我国11个城市变应性鼻炎自报患病率调查[J].中华耳鼻咽喉头颈外科杂志, 2007, 42(5):378-384.
[2] BOUSQUET J,VAN CAUWENBERGE P,BACHERT C,et al.Allergic rhintits and its impact on asthma[J]. J Allergy Clin Immunol, 2001, 108:147-334.
[3] 田勇泉.耳鼻咽喉-头颈外科学[M]. 北京:人民卫生出版社,2006:74-74.
[4] 陈建军,孔维佳,项济生,等.舌下含服免疫治疗依从性分析及对策[J].临床耳鼻咽喉头颈外科杂志, 2010, 24(5):203-206.
[5] ROSS R N, NELSON H S, FINEGOLE I. Effectiveness of specific immunotherapy in the treatment of allergic rhinitis:an analysis of randomized, prospective, single-or double-blind, placebo-controlled studies[J]. Clin Ther, 2000,22:342-350.
[6] ROUVER S, DIDIER A, DEMOLY P, et al. Numeric score and visual analog scale in assessing seasonal allergic rhinitis severity[J]. Rhinology, 2010, 48:285-291.
[7] SENTI G, VAVRICKA B M, GRAF N, et al. Evaluation of visual analog scales for the assessment of symptom severity in allergic rhinoconjunctivitis[J]. Ann Allergy Asthma Immunol, 2007, 98:134-138.
[8] 开月梅,石兰萍,张杨,等.护理干预对变应性鼻炎免疫治疗患者依从性的影响[J].中国实用护理杂志, 2008,24(1):3-6.
[9] 邱前辉,苏志文.影响变应性鼻炎脱敏治疗效果的多因素多元回归分析[J].广东医学, 1999, 20(1):47-48.
-
计量
- 文章访问数: 178
- PDF下载数: 127
- 施引文献: 0